Lilly has been solidly investing in research and development (R&D) throughout 2024. In April, the company announced the ...

UNICEF is working to strengthen under-resourced health systems around the world to improve outcomes for children and family ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

This week’s news from the life sciences includes Eli Lilly's investment in a Cambridge-Singapore biotech, Stealth ...

Beyond semaglutide, participants in the latest study were using drugs including Eli Lilly’s weight loss and diabetes drug ...

The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

The funding will help build a laboratory to assist with clinical trials of the company’s diagnostic blood-based system.

Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence ...

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb ...

Companies usually only issue stock splits after extended periods of strong returns, and a stock split is a sign a company's ...

Hunsaker finds an improvement in the “volume and variety” of funding from the UKIB and others since his original report into ...